Engineered Nanoparticles for Drug Delivery in Cancer Therapy
The DOI matches its Crossref record; 579 of the 579 references it cites were found in a registry or an index.
Abstract
In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a number of issues associated with conventional therapeutic agents, including their poor water solubility (at least, for most anticancer drugs), lack of targeting capability, nonspecific distribution, systemic toxicity, and low therapeutic index. Over the past several decades, remarkable progress has been made in the development and application of engineered nanoparticles to treat cancer more effectively. For example, therapeutic agents have been integrated with nanoparticles engineered with optimal sizes, shapes, and surface properties to increase their solubility, prolong their circulation half‐life, improve their biodistribution, and reduce their immunogenicity. Nanoparticles and their payloads have also been favorably delivered into tumors by taking advantage of the pathophysiological conditions, such as the enhanced permeability and retention effect, and the spatial variations in the pH value. Additionally, targeting ligands (e.g., small organic molecules, peptides, antibodies, and nucleic acids) have been added to the surface of nanoparticles to specifically target cancerous cells through selective binding to the receptors overexpressed on their surface. Furthermore, it has been demonstrated that multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be delivered through the same carrier to enable combination therapy with a potential to overcome multidrug resistance, and real‐time readout on the treatment efficacy. It is anticipated that precisely engineered nanoparticles will emerge as the next‐generation platform for cancer therapy and many other biomedical applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Vasculature plays an essential role in the growth and metastasis of malignant tumors [103].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
Citations
Cites
Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Chemistry and Properties of Nanocrystals of Different Shapes
Burda, C., Chen, X., Narayanan, R., & El-Sayed, M. A. (2005) · Chemical Reviews · doi:10.1021/cr030063a · Cited by 7,230
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Research works printed but not linked: 29
- Aruna U., 2013, Inter. J. Inn. Pharm. Res., 4, 318
- Langer R., 1998, Nature, 392, 5
- Petre C. E., 2007, Int. J. Nanomed., 2, 277
- Lao J., 2013, J. Drug Delivery, 456409
- Saif M. W., 2007, JOP, 8, 166
- Matsumura Y., 1986, Cancer Res., 46, 6387
- Xu G., 2001, Clin. Cancer Res., 7, 3314
- 10.1016/j.addr.2012.09.008 · doi:10.1016/j.addr.2012.09.008 · Paper page
- Pundir S., 2013, Int. J. Drug Res. Technol., 3, 12
- 10.1021/jp077468 · doi:10.1021/jp077468
- Mohanraj V. J., 2006, J. Pharm. Res., 5, 561
- Ma Y. D., 2011, Int. J. Nanomed., 6, 2679
- 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F · doi:10.1002/(sici)1097-4636(199908)46:2<236::aid-jbm13>3.0.co;2-f
- Krishna R., 2000, Eur. J. Cancer Sci., 11, 265
- Kettiger H., 2013, Int. J. Nanomed., 8, 3255
- Yuan F., 1995, Cancer Res., 55, 3752
- Jain R. K., 1987, Cancer Res., 47, 3039
- 10.1021/nn900002m · DOI · Paper page
- Chidambaram M., 2012, Int. J. Pharm. Sci., 2, 117
- 10.1039/C1CS15237H · DOI · Paper page
- 10.1038/nnano.2007.223 · DOI · Paper page
- Mohanraj V. J., 2006, Trop. J. Pharm. Res., 5, 561
- Hong R. L., 1999, Clin. Cancer Res., 5, 3645
- Shamsipour F., 2009, Avicenna J. Med. Biotechnol., 1, 27
- Park J. W., 2002, Clin. Cancer Res., 8, 1172
- Uppada S. B., 2014, Int. J. Nanomed., 9, 43
- Bangham A. D., 1965, J. Mol. Biol., 13, 227
- Mueller C., 1994, Methods Cell Sci., 16, 183
- 10.1016/j.cbpa.2005.10.005 · DOI
Cited by
Items 601–700 of 1,005
Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy
Lee, E. S., Shin, J. M., Son, S., Ko, H., Um, W., Song, S. H., Lee, J. A., & Park, J. H. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801320 · Cited by 54
Underlying mechanisms and drug intervention strategies for the tumour microenvironment
Li, H., Zhou, L., Zhou, J., Li, Q., & Ji, Q. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01893-y · Cited by 55
Lv, S., Jing, R., Liu, X., Shi, H., Shi, Y., Wang, X., Zhao, X., Cao, K., & Lv, Z. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s329621 · Cited by 51
“In addition, DDSs should also have high drug loading, a controllable release capacity and biological safety.(18,19) In an effort to achieve the ideal DDS, researchers have proposed a variety of strategies to better target the nanocarriers to tumor cells in bladder tissue.”
BackgroundDelivery strategies in treatments of leukemia
Ci, T., Zhang, W., Qiao, Y., Li, H., Zang, J., Li, H., Feng, N., & Gu, Z. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00755f · Cited by 53
Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges
Hu, X., Zhang, Y.-S., Liu, Y., Wang, N., Zeng, X., & Zhang, L. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01637-w · Cited by 46
Self-citationCarrier-free nanoplatforms from natural plants for enhanced bioactivity
Li, Z., Xu, X., Wang, Y., Kong, L., & Han, C. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.09.013 · Cited by 56
“Nanodrug delivery and targeting systems have provided advanced opportunities in recent years and can significantly improve therapeutic efficacy for the treatment of human diseases [7,8].”
BackgroundTheranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances
Kasi, P. B., Mallela, V. R., Ambrożkiewicz, F., Trailin, A. V., Liška, V., & Hemminki, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097922 · Cited by 57
“In contrast, tumor tissues have a wide vascular wall gap and poor structural integrity, which makes them more susceptible to exposure to nano-drugs with a small diameter [81].”
BackgroundManufacture and Drug Delivery Applications of Silk Nanoparticles
Wongpinyochit, T., Johnston, B. F., & Seib, F. P. (2016) · Journal of Visualized Experiments · doi:10.3791/54669 · Cited by 51
Nanomedicines for dysfunctional macrophage-associated diseases
He, H., Ghosh, S., & Yang, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.032 · Cited by 53
“In comparison to traditional formulations, nanoparticle-based nanomedicines offer many distinctive characteristics such as: 1) improved bioavailability of poorly water-soluble drugs; 2) extended blood half-life through better protection before reaching the targets; 3) controlled drug release; 4) co-delivery of multipl…”
BackgroundThe Current Role of Cell-Penetrating Peptides in Cancer Therapy
Feni, L., & Neundorf, I. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-66095-0_13 · Cited by 53
Zhu, C., & Xia, Y. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00492c · Cited by 51
Crosslinked casein-based micelles as a dually responsive drug delivery system
Picchio, M. L., Cuggino, J. C., Nagel, G., Wedepohl, S., Minari, R. J., Igarzabal, C. I. Á., Gugliotta, L. M., & Calderón, M. (2018) · Polymer Chemistry · doi:10.1039/c8py00600h · Cited by 50
Cancer hallmarks and malignancy features: Gateway for improved targeted drug delivery
Souho, T., Lamboni, L., Xiao, L. J., & Yang, G. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.08.001 · Cited by 56
Mesoporous Colloidal Photonic Crystal Particles for Intelligent Drug Delivery
Gu, X., Liu, Y., Chen, G., Wang, H., Shao, C., Chen, Z., Lu, P., & Zhao, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b11175 · Cited by 50
Lopes, R. C. F. G., Silvestre, Ó. F., Faria, A. R., Vale, M. L. C., Marques, E. F., & Nieder, J. B. (2018) · Nanoscale · doi:10.1039/c8nr06346j · Cited by 52
Pon‐On, W., Tithito, T., Maneeprakorn, W., Phenrat, T., & Tang, I. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.11.076 · Cited by 51
Le, D. H. T., Commandeur, U., & Steinmetz, N. F. (2019) · ACS Nano · doi:10.1021/acsnano.8b09462 · Cited by 53
Wu, Y., Lv, S., Li, Y., He, H., Ji, Y. I., Zheng, M., Liu, Y., & Yin, L. (2019) · Biomaterials Science · doi:10.1039/c9bm01662g · Cited by 60
Ou, Y.-H., Liang, J., Czarny, B., Wacker, M. G., Yu, V. C. K., Wang, J., & Pastorin, G. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.02.006 · Cited by 56
Grosso, R., & de‐Paz, M. ‐. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060854 · Cited by 54
Li, H., Yang, Y., & Sun, T. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.889291 · Cited by 64
“Generally, high charge (>30 mV), whether positive or negative, are generally more stable because of electrostatic repulsion (Yan et al., 2008; Hunter et al., 2014; Sun et al., 2014; Hlavaty et al., 2016; Saito et al., 2019a; Saito et al., 2019b).”
BackgroundSelf-citationLi, Q., Chen, M., Chen, D., & Wu, L. (2016) · Chemistry of Materials · doi:10.1021/acs.chemmater.6b02604 · Cited by 51
Yang, D., Yang, G., Gai, S., He, F., Lv, R., Dai, Y., & Yang, P. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00462 · Cited by 50
Lee, S. Y., Park, J.-H., Ko, S.-H., Shim, J.-S., Kim, D., & Cho, H. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b06582 · Cited by 54
Multiscale Modeling and Simulation of Nano‐Carriers Delivery through Biological Barriers—A Review
Shi, X., & Tian, F. (2019) · Advanced Theory and Simulations · doi:10.1002/adts.201800105 · Cited by 50
A guide towards long-term functional electrodes interfacing neuronal tissue
Renz, A. F., Reichmuth, A. M., Stauffer, F., Thompson-Steckel, G., & Vörös, J. (2018) · Journal of Neural Engineering · doi:10.1088/1741-2552/aae0c2 · Cited by 50
“Drug delivery systems often contain either a reservoir from which a drug is released diffusively or consist of a degradable material that continuously releases the drug via material erosion [139].”
BackgroundMa, Y., Zhao, W., Li, Y., Pan, Y., Wang, S., Zhu, Y., Kong, L., Guan, Z., Wang, J., Zhang, L., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.033 · Cited by 51
Yılmaz, M., Karanastasis, A. A., Chatziathanasiadou, Μ. V., Oğuz, M., Kougioumtzi, A., Clemente, N., Kellici, T. F., Zafeiropoulos, N. E., Avgeropoulos, A., Mavromoustakos, T., et al. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00748 · Cited by 50
Nanomedicines for the Delivery of Biologics
Wahlich, J. C., Desai, A. S., Greco, F., Hill, K. J., Jones, A. T., Mrsny, R. J., Pasut, G., Perrie, Y., Seib, F. P., Seymour, L. W., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050210 · Cited by 53
“The use of nanomedicines in cancer therapies has received particular attention [8] due mainly to their potential to improve drug therapeutic index.”
BackgroundAbolhassani, H., Safavi, M. S., Handali, S., Nosrati, M., & Shojaosadati, S. A. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1820032 · Cited by 50
Iglesias, N., Galbis, E., Valencia, C., Díaz, M. J., Lacroix, B., & de‐Paz, M. ‐. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.10.006 · Cited by 51
Zheng, Y., Li, Z., Yang, Y., Shi, H., Chen, H., & Gao, Y. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153788 · Cited by 51
Coordination‐Driven Metal‐Polyphenolic Nanoparticles toward Effective Anticancer Therapy
Wu, D., Zhou, B., Li, J., Wang, X., Li, B., & Liang, H. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202200559 · Cited by 50
Shim, N., Jeon, S. I., Yang, S., Park, J. Y., Jo, M., Kim, J., Choi, J., Yun, W. S., Kim, J., Lee, Y. J., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121806 · Cited by 49
Smart Delivery Systems Responsive to Cathepsin B Activity for Cancer Treatment
Egorova, V. S., Kolesova, E. P., Lopus, M., Yan, N., Parodi, A., & Zamyatnin, A. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071848 · Cited by 52
pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery
Sun, H., Li, X., Liu, Q., Sheng, H., & Zhu, L. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2349124 · Cited by 55
Zhou, H., Wang, X., Tang, J., & Yang, Y. (2016) · Polymers · doi:10.3390/polym8080277 · Cited by 49
Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes
Chen, Q., Shang, W., Zeng, C., Wang, K., Liang, X., Chi, C., Liang, X. Y., Yang, J., Fang, C., & Tian, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15642 · Cited by 48
Gao, D., Gao, J., Xu, M. T., Cao, Z., Zhou, L., Li, Y., Xie, X., Jiang, Q. Y., Wang, W., & Liu, J. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00761 · Cited by 49
Ferreira, J. T., Pina, J., Ribeiro, C., Fernandes, R., Tomé, J. P. C., Rodríguez‐Morgade, M. S., & Torres⊗, T. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00958e · Cited by 49
Multiresponsive Nanogels for Targeted Anticancer Drug Delivery
Zhang, Q. M., Colazo, J. M., Berg, D., Mugo, S. M., & Serpe, M. J. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00325 · Cited by 49
Singh, R., Patil, S., Singh, N., & Gupta, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-06014-4 · Cited by 49
Wang, L., Lin, H., Chi, X., Sun, C., Huang, J., Tang, X., Chen, H., Luo, X., Yin, Z., & Gao, J. (2018) · Small · doi:10.1002/smll.201801612 · Cited by 49
Synergy between polymer crystallinity and nanoparticles size for payloads release
Niyom, Y., Phakkeeree, T., Flood, A. E., & Crespy, D. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2019.04.085 · Cited by 54
Bare Iron Oxide Nanoparticles as Drug Delivery Carrier for the Short Cationic Peptide Lasioglossin
Turrina, C., Berensmeier, S., & Schwaminger, S. P. (2021) · Pharmaceuticals · doi:10.3390/ph14050405 · Cited by 52
“Endosome and lysosome have an especially low pH of 5 [20].”
BackgroundIntercalated kaolinite as an emerging platform for cancer therapy
Zhang, Y., Huang, P. F., Long, M., Liu, S., Yang, H., Yuan, S., & Chang, S. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9364-8 · Cited by 48
Self-citationXia, B., Wang, B., Chen, Z., Zhang, Q., & Shi, J. (2015) · Advanced Materials Interfaces · doi:10.1002/admi.201500715 · Cited by 52
Xu, Z., Hou, M., Shi, X., Gao, Y.-E., Xue, P., Liu, S., & Kang, Y. (2017) · Biomaterials Science · doi:10.1039/c6bm00800c · Cited by 48
Peptide binding to metal oxide nanoparticles
Schwaminger, S. P., Blank-Shim, S. A., Scheifele, I., Fraga‐García, P., & Berensmeier, S. (2017) · Faraday Discussions · doi:10.1039/c7fd00105c · Cited by 48
Hussain, M., Raja, N. I., Mashwani, Z., Iqbal, M., Ejaz, M., Yasmeen, F., & Sohail, S. (2017) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2016.0256 · Cited by 49
Solid matrix-based lipid nanoplatforms as carriers for combinational therapeutics in cancer
Gupta, B., Yong, C. S., & Kim, J. O. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0337-5 · Cited by 48
Wang, Y., Wang, L., Yan, M., Dong, S., & Hao, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b05502 · Cited by 49
Lab-on-a-chip systems for photodynamic therapy investigations
Chudy, M., Tokarska, K., Jastrzębska, E., Bułka, M., Drozdek, S., Lamch, Ł., Wilk, K. A., & Brzózka, Z. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.10.013 · Cited by 48
DARWISH, S. A. F., Sadeghiani, N., Fong, S., Mozaffari, S., Hamidi, P., Withana, T., Yang, S., Tiwari, R. K., & Parang, K. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.042 · Cited by 50
Lu, Z., Zhang, Z., & Tang, Y. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00640 · Cited by 48
Dispersed graphene materials of biomedical interest and their toxicological consequences
Patil, R., Bahadur, P., & Tiwari, S. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.102051 · Cited by 48
Abolhassani, H., & Shojaosadati, S. A. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110534 · Cited by 48
Li, M., Bian, X., Chen, X., Fan, N., Zou, H., Bao, Y., & Zhou, Y. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2032876 · Cited by 47
“The folic acidcontaining liposomes bind to FRs on RB cells and accumulate due to the enhanced permeability and retention (EPR) effect (Sun et al., 2014; Wang et al., 2016; Kalyane et al., 2019).”
BackgroundKoklesová, L., Jakubíková, J., Cholujová, D., Samec, M., Mazuráková, A., Šudomová, M., Péč, M. J., Hassan, S. T. S., Biringer, K., Büsselberg, D., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1121950 · Cited by 52
“, cancer) cells thanks to their specific selective binding to the overexpressed receptors (Sun et al., 2014).”
BackgroundPoly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination
Mohammadzadeh, V., Rahiman, N., Cabral, H., Quader, S., Zirak, M. R., Yazdi, M. E. T., Jaafari, M. R., & Alavizadeh, S. H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.08.049 · Cited by 50
More than a delivery system: the evolving role of lipid-based nanoparticles
Karmaker, S., Rosales, P. D., Tirumuruhan, B., Viravalli, A., & Boehnke, N. (2025) · Nanoscale · doi:10.1039/d4nr04508d · Cited by 62
Gu, L., Shi, T., Sun, Y., You, C., Wang, S., Wen, G., Chen, L., Zhang, X., Zhu, J., & Sun, B. (2017) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2017.1296347 · Cited by 48
Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy
Glass, S., Gonzalez‐Fajardo, L., Beringhs, A. O., & Lü, X. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7370 · Cited by 50
“…pharmaceutical delivery agents due to their (i) highly tunable size, charge, and surface and core chemistries; (ii) biocompatibility and limited toxicity; (iii) high drug/ cargo loading capacities; and (iv) ability to extravasate into tumor tissues via punctated (‘‘leaky’’) tumor vasculature (53).”
Song, C., Dou, Y., Yuwen, L., Sun, Y., Chen, D., Li, F., Yang, Y., & Wang, L. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00587g · Cited by 47
Kyzioł, A., Łukasiewicz, S., Sebastián, V., Kuśtrowski, P., Kozieł, M., Majda, D., & Cierniak, A. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111300 · Cited by 47
Francesco, M. D., Celia, C., Cristiano, M. C., d’Avanzo, N., Ruozi, B., Mircioiu, C., Cosco, D., Marzio, L. D., & Fresta, M. (2021) · ACS Omega · doi:10.1021/acsomega.0c05350 · Cited by 49
“8 The fi rst generation of nanomedicine was liposomes, or Bangham ’ s vesicles.”
Almoshari, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030600 · Cited by 46
“For instance, nanoparticles are frequently modified to become more hydrophilic, allowing them to remain in the bloodstream for more extended periods, resulting in a larger concentration of drugs at the tumor site and a longer half-life overall [18].”
BackgroundDevelopment of delivery strategies for CRISPR‐Cas9 genome editing
Liu, Q., Yang, J., Xing, Y., Zhao, Y., & Liu, Y. (2023) · BMEMat · doi:10.1002/bmm2.12025 · Cited by 53
Mohapatra, P., Gopikrishnan, M., Doss, C. G. P., & Chandrasekaran, N. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s442520 · Cited by 53
“130,131 Nanomaterial-based BBB crossing mechanisms and strategies, BBB transportability study techniques, and treatment for NDs, such as AD and PD, frequently fail because chemicals have trouble entering the brain due to the BBB. 132 Numerous drug delivery techniques demonstrate the successful…”
BackgroundShen, S., Sun, C., Du, X., Li, H., Liu, Y., Xia, J., Zhu, Y., & Wang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.026 · Cited by 47
Small molecular nanomedicines made from a camptothecin dimer containing a disulfide bond
Pei, Q., Hu, X., Li, Z., Xie, Z., & Jing, X. (2015) · RSC Advances · doi:10.1039/c5ra18586f · Cited by 46
Lv, G., Qiu, L., Liu, G., Wang, W., Li, K., Zhao, X., & Lin, J. (2016) · Dalton Transactions · doi:10.1039/c6dt03783f · Cited by 46
Landarani‐Isfahani, A., Moghadam, M., Mohammadi, S., Royvaran, M., Moshtael‐Arani, N., Rezaei, S., Tangestaninejad, S., Mirkhani, V., & Mohammadpoor‐Baltork, I. (2017) · Langmuir · doi:10.1021/acs.langmuir.7b00742 · Cited by 47
Self-assembly regulated anticancer activity of platinum coordinated selenomethionine
Li, T., Xiang, W., Li, F., & Xu, H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.12.001 · Cited by 47
Liu, T., Qiao, Z., Wang, J., Zhang, P., Zhang, Z., Guo, D., & Yang, X. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.09.078 · Cited by 47
Yan, H., Chen, J., Li, Y., Bai, Y., Wu, Y., Sheng, Z., Song, L., Liu, C., & Zhang, H. (2018) · Biomaterials Science · doi:10.1039/c8bm00767e · Cited by 47
Length effect of stimuli-responsive block copolymer prodrug filomicelles on drug delivery efficiency
Ke, W., Lu, N., Japir, A. A.-W. M. M., Zhou, Q., Xi, L., Wang, Y., Dutta, D., Zhou, M., Pan, Y., & Ge, Z. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.012 · Cited by 48
Sun, W., Li, S., Tang, G., Luo, Y., Ma, S., Sun, S., Ren, J., Gong, Y. Q., & Xie, C. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s230524 · Cited by 47
“11 These unique features promote NMOFs ’ widely application in delivering imaging contrast agents and anti-cancer drugs as attractive theranostic platforms.”
BackgroundDual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy
Zhang, X., Zhu, T., Miao, Y., Zhou, L., & Zhang, W. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00691-6 · Cited by 48
“com 1 Department of Pharmacy/Respiratory Diseases, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China Full list of author information is available at the end of the article Background Plenty of smart drug delivery systems have been proposed to improve the therapeutic efficacy and reduce unde…”
BackgroundSmart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics
Li, X., Gao, Y., Li, H.-L., Majoral, J., Shi, X.-Y., & Pich, A. (2023) · Progress in Materials Science · doi:10.1016/j.pmatsci.2023.101170 · Cited by 37
de Barros, D. P. C., Santos, R., Reed, P., Fonseca, L. P., & Oliva, A. (2022) · Molecules · doi:10.3390/molecules27248818 · Cited by 50
“The high amount of quercetin dissolved in the liquid shell with a large surface area may account for the fast release at th initial stage, and the encapsulated quercetin in the semi-solid core of NLCs may lead to the sustained release in the later phase [52].”
BackgroundHu, J., He, X., Cai, J., Zhang, Z., Bai, X., Zhang, S., Geng, B., Pan, D., & Shen, L. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.148561 · Cited by 45
Externally controlled drug release using a gold nanorod contained composite membrane
Kim, K., Jo, M., Jeong, S., Palanikumar, L., Rotello, V. M., Ryu, J., & Park, M. (2016) · Nanoscale · doi:10.1039/c6nr00362a · Cited by 45
Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines
Balasubramanian, V., Liu, Z., Hirvonen, J. J., & Santos, H. A. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700432 · Cited by 53
Spatial Analysis of Metal–PLGA Hybrid Microstructures Using 3D SERS Imaging
Strozyk, M. S., de Aberasturi, D. J., Gregory, J. V., Brust, M., Lahann, J., & Liz‐Marzán, L. M. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201701626 · Cited by 44
He, J., Chen, J., Lin, S., Niu, D., Hao, J., Jia, X., Li, N., Gu, J., Li, Y., & Shi, J. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00488 · Cited by 45
Cui, P., Zhuang, W., Hu, X., Xing, L., Yu, R.-Y., Qiao, J.-B., He, Y., Li, F., Ling, D., & Jiang, H. (2018) · Chemical Communications · doi:10.1039/c8cc04363a · Cited by 46
Development of optical nanoprobes for molecular imaging of reactive oxygen and nitrogen species
Xu, Z. J., & Pu, K. (2018) · Nano Research · doi:10.1007/s12274-018-2135-4 · Cited by 45
Effect of annealing on structural and magnetic properties of NiFe2O4/ZnFe2O4 nanocomposites
Anumol, C. N., Chithra, M., Shalini, M. G., & Sahoo, S. C. (2018) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2018.08.036 · Cited by 45
Biodegradable and Renal-Clearable Hollow Porous Iron Oxide Nanoboxes for in Vivo Imaging
Wei, R., Cai, Z., Ren, B. W., Li, A., Lin, H., Zhang, K., Chen, H., Shan, H., Ai, H., & Gao, J. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b03564 · Cited by 45
Braga, C. B., Perli, G., Becher, T. B., & Ornelas, C. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00058 · Cited by 45
Multifunctional nanomedicines for targeting epidermal growth factor receptor in colorectal cancer
Akbarzadeh-Khiavi, M., Safary, A., Barar, J., Ajoolabady, A., Somi, M. H., & Omidi, Y. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03305-z · Cited by 48
Dou, X., Keywanlu, M., Tayebee, R., & Mahdavi, B. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.115557 · Cited by 45
Facile fabrication of polydopamine nanotubes for combined chemo-photothermal therapy
Sun, Y., & Davis, E. W. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01338e · Cited by 42
Cell membrane-engineered nanoparticles for cancer therapy
Liu, W., & Huang, Y. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00709f · Cited by 44
Nanotherapeutics targeting autophagy regulation for improved cancer therapy
Liu, Y., Wang, Y., Zhang, J., Peng, Q., Wang, X., Xiao, X., & Shi, K. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.019 · Cited by 48
Surfactant Directed Growth of Gold Metal Nanoplates by Chemical Vapor Deposition
Griffiths, M. B. E., Koponen, S. E., Mandia, D. J., McLeod, J. F., Coyle, J. P., Sims, J. J., Giorgi, J. B., Sirianni, E., Yap, G., & Barry, S. (2015) · Chemistry of Materials · doi:10.1021/acs.chemmater.5b02712 · Cited by 39
Reconfigurable Peptide Nanotherapeutics at Tumor Microenvironmental pH
Qiao, Z., Zhao, W., Gao, Y., Cong, Y., Zhao, L., Hu, Z., & Wang, H. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b09033 · Cited by 44
Ricci, V., Zonari, D., Cannito, S., Marengo, A., Scupoli, M. T., Malatesta, M., Carton, F., Boschi, F., Berlier, G., & Arpicco, S. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.01.072 · Cited by 44
Nano-Based Systems and Biomacromolecules as Carriers for Metallodrugs in Anticancer Therapy
Poursharifi, M., Wlodarczyk, M. T., & Mieszawska, A. J. (2018) · Inorganics · doi:10.3390/inorganics7010002 · Cited by 45
Metadata
- Authors
- Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y.
- Affiliations
- Georgia Institute of Technology (US)
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2014-10-07
- Volume
- 53
- Issue
- 46
- Pages
- 12320-12364
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2134726513
- Cited by
- 2,164
- References
- 578
- Citations by year
- 2026: 57 · 2025: 146 · 2024: 163 · 2023: 153 · 2022: 209 · 2021: 200 · 2020: 221 · 2019: 237 · 2018: 257 · 2017: 230 · 2016: 180 · 2015: 109 · 2014: 2
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Angewandte Chemie International Edition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- engineered nanoparticles, drug delivery, cancer therapy, targeted drug delivery, enhanced permeability and retention effect, pH-responsive delivery, tumor-targeting ligands, tissue distribution, circulation half-life, immunogenicity, combination therapy, multidrug resistance, contrast media, theranostics, nanoparticle surface modification
- MeSH terms
- Animals, Antineoplastic Agents, Delayed-Action Preparations, Humans, Neoplasms, Drug Delivery Systems, Nanotechnology, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.